International Clinical Trials in Musculoskeletal

Albania

• Post-Menopausal Osteoporosis: BONCURE Study: A Study of Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis on Bisphosphonate Therapy.
  Tirana; Research Site:
  
  

Argentina

• Lupus: A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.
  Buenos Aires ; Research Site:
  
  
• Lupus: A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.
  Córdoba; Research Site:
  
  
• Lupus: A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.
  San Isidro; Research Site:
  
  
• Lupus: A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.
  Tucuman; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study of Bonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal Women With Osteoporosis at High Risk for Renal Disease.
  Buenos Aires ; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study of Bonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal Women With Osteoporosis at High Risk for Renal Disease.
  Santa Fe; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
  Buenos Aires ; Research Site:
  
  
• Rheumatoid Arthritis: A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis.
  Buenos Aires ; Research Site:
  
  
• Rheumatoid Arthritis: A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis.
  Córdoba; Research Site:
  
  
• Rheumatoid Arthritis: A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis.
  Tucuman; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
  Buenos Aires ; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
  Tucuman; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
  Buenos Aires ; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
  Mar Del Plata; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
  Rosario; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Buenos Aires ; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Buenos Aires ; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Rosario; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Tocilizumab in Patients Completing Treatment in WA17822
  Buenos Aires ; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Buenos Aires ; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Rosario; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Buenos Aires ; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
  Buenos Aires ; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
  Rosario; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Buenos Aires ; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Rosario; Research Site:
  
  
• Rheumatoid Arthritis: SCORE Study: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate.
  Buenos Aires ; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.
  Buenos Aires ; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.
  Córdoba; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.
  San Juan; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.
  San Miguel De Tucuman; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.
  Tucuman; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
  Buenos Aires ; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
  Córdoba; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
  San Juan; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
  San Miguel De Tucuman; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
  Tucuman; Research Site:
  
  

Australia

• Lupus: A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.
  Parkville; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Who Have Received Previous Bonviva Treatment
  St. Leonards; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Who Have Received Previous Bonviva Treatment
  Sydney; Research Site:
  
  
• Post-Menopausal Osteoporosis: DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
  Darlinghurst; Research Site:
  
  
• Post-Menopausal Osteoporosis: DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
  Melbourne; Research Site:
  
  
• Post-Menopausal Osteoporosis: DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
  Nedlands; Research Site:
  
  
• Post-Menopausal Osteoporosis: DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
  St. Leonards; Research Site:
  
  
• Post-Menopausal Osteoporosis: DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
  Sydney; Research Site:
  
  
• Post-Menopausal Osteoporosis: MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
  Adelaide; Research Site:
  
  
• Post-Menopausal Osteoporosis: MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
  Parkville; Research Site:
  
  
• Post-Menopausal Osteoporosis: MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
  Perth; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
  Hobart; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
  Shenton Park; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
  Campsie; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
  Malvern; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
  Malvern; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
  Maroochydore; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Maroochydore; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Shenton Park; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Woolloongabba; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Maroochydore; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Shenton Park; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis.
  Perth; Research Site:
  
  
• Rheumatoid Arthritis: A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
  Caboolture; Research Site:
  
  
• Rheumatoid Arthritis: A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
  Fitzroy; Research Site:
  
  
• Rheumatoid Arthritis: A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
  Kipparing; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
  Coffs Harbour; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
  Maroochydore; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
  Melbourne; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
  Sydney; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Tocilizumab in Patients Completing Treatment in WA17822
  Adelaide; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Tocilizumab in Patients Completing Treatment in WA17822
  Maroochydore; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Tocilizumab in Patients Completing Treatment in WA17822
  Shenton Park; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Sydney; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Adelaide; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Malvern; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Melbourne; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Newcastle; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Shenton Park; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis
  St. Leonards; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Adelaide; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Maroochydore; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Shenton Park; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
  Malvern; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
  Shenton Park; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
  Sydney; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Efficacy and Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis
  Darlinghurst; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Efficacy and Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis
  Maroochydore; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Efficacy and Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis
  Melbourne; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Efficacy and Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis
  Perth; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
  Maroochydore; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
  Melbourne; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
  Perth; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
  Adelaide; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
  Hobart; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
  Shenton Park; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
  Sydney; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
  Woolloongabba; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Hobart; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Malvern; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Shenton Park; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Sydney; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Woolloongabba; Research Site:
  
  
• Rheumatoid Arthritis: Maraviroc in Rheumatoid Arthritis
  Heidelberg, VIC; Austin Health
  
  
• Rheumatoid Arthritis: Maraviroc in Rheumatoid Arthritis
  Hobart, Tasmania; Menzies Research Institute
  
  
• Rheumatoid Arthritis: Maraviroc in Rheumatoid Arthritis
  Maroochydore, QLD; Rheumatology Research Unit Sunshine Coast
  
  
• Rheumatoid Arthritis: Maraviroc in Rheumatoid Arthritis
  Woodville, SA; Queen Elizabeth Hospital, Department of Rheumatology
  
  

Austria

• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Bregenz; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Graz; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Innsbruck; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Linz; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Salzburg; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Vöcklabruck; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Wien; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
  Klagenfurt; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
  Wien; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Graz; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Salzburg; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Wien; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Tocilizumab in Patients Completing Treatment in WA17822
  Wien; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Wien; Research Site:
  
  

Belgium

• Lupus: A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.
  Bruxelles; Research Site:
  
  
• Lupus: A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.
  Liege; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
  Gent; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
  Leuven; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
  Liege; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With Bonviva
  Liege; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With Bonviva
  Merksem; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Who Have Received Previous Bonviva Treatment
  Bruxelles; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Who Have Received Previous Bonviva Treatment
  Liege; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Aalst; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Antwerpen; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Aye; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Braine L'Alleud; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Brugge; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Bruxelles; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Charleroi; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Dinant; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Ekeren; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Genk; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Gent; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Godinne; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Hasselt; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Jambes; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Knokke; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Kortrijk; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  La Louviere; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Liege; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Mechelen; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Merksem; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Mons; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Oostende; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Roeselare; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Sijsele; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Tournai; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Turnhout; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Waremme; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Wilrijk; Research Site:
  
  
• Post-Menopausal Osteoporosis: DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
  Bruxelles; Research Site:
  
  
• Post-Menopausal Osteoporosis: DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
  Liege; Research Site:
  
  
• Post-Menopausal Osteoporosis: MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
  Liege; Research Site:
  
  
• Post-Menopausal Osteoporosis: MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
  Merksem; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
  Gent; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Brugge; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Bruxelles; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Charleroi; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Gent; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Leuven; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Merksem; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Montignies S/ Sambre; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Brugge; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Bruxelles; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Charleroi; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Gent; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Merksem; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Montignies S/ Sambre; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis.
  Gent; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis.
  Leuven; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
  Gent; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
  Aalst; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
  Hasselt; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
  Merksem; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
  Gent; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Retreatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on anti-TNFalfa Therapy
  Bruxelles; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Retreatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on anti-TNFalfa Therapy
  Gent; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNFalfa Therapy
  Bruxelles; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNFalfa Therapy
  Gent; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNFalfa Therapy
  Liege; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Hasselt; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Merksem; Research Site:
  
  

Bosnia and Herzegovina

• Post-Menopausal Osteoporosis: BONCURE Study: A Study of Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis on Bisphosphonate Therapy.
  Banja Luka; Research Site:
  
  
• Post-Menopausal Osteoporosis: BONCURE Study: A Study of Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis on Bisphosphonate Therapy.
  Sarajevo; Research Site:
  
  
• Post-Menopausal Osteoporosis: BONCURE Study: A Study of Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis on Bisphosphonate Therapy.
  Tuzla; Research Site:
  
  

Brazil

• Lupus: A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.
  Rio De Janeiro; Research Site:
  
  
• Lupus: A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.
  Sao Paulo; Research Site:
  
  
• Lupus: A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.
  Sorocaba; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study of Bonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal Women With Osteoporosis at High Risk for Renal Disease.
  Brasilia; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study of Bonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal Women With Osteoporosis at High Risk for Renal Disease.
  Curitiba; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study of Bonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal Women With Osteoporosis at High Risk for Renal Disease.
  Goiania; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study of Bonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal Women With Osteoporosis at High Risk for Renal Disease.
  Porto Alegre; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study of Bonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal Women With Osteoporosis at High Risk for Renal Disease.
  Rio De Janeiro; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study of Bonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal Women With Osteoporosis at High Risk for Renal Disease.
  Sao Paulo; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study of Bonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal Women With Osteoporosis at High Risk for Renal Disease.
  Vitoria; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
  Brasilia; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
  Sao Paulo; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
  Vitoria; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With Bonviva
  Sao Paulo; Research Site:
  
  
• Post-Menopausal Osteoporosis: MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
  Campinas; Research Site:
  
  
• Post-Menopausal Osteoporosis: MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
  Curitiba; Research Site:
  
  
• Post-Menopausal Osteoporosis: MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
  Porto Alegre; Research Site:
  
  
• Post-Menopausal Osteoporosis: MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
  Sao Paulo; Research Site:
  
  
• Rheumatoid Arthritis: A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis.
  Belem; Research Site:
  
  
• Rheumatoid Arthritis: A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis.
  Brasilia; Research Site:
  
  
• Rheumatoid Arthritis: A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis.
  Campinas; Research Site:
  
  
• Rheumatoid Arthritis: A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis.
  Curitiba; Research Site:
  
  
• Rheumatoid Arthritis: A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis.
  Florianopolis; Research Site:
  
  
• Rheumatoid Arthritis: A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis.
  Fortaleza; Research Site:
  
  
• Rheumatoid Arthritis: A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis.
  Goiania; Research Site:
  
  
• Rheumatoid Arthritis: A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis.
  Nova Lima; Research Site:
  
  
• Rheumatoid Arthritis: A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis.
  Porto Alegre; Research Site:
  
  
• Rheumatoid Arthritis: A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis.
  Recife; Research Site:
  
  
• Rheumatoid Arthritis: A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis.
  Ribeirão Preto; Research Site:
  
  
• Rheumatoid Arthritis: A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis.
  Rio De Janeiro; Research Site:
  
  
• Rheumatoid Arthritis: A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis.
  Salvador; Research Site:
  
  
• Rheumatoid Arthritis: A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis.
  Sao Paulo; Research Site:
  
  
• Rheumatoid Arthritis: A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis.
  Vitoria; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
  Brasilia; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
  Curitiba; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
  Goiania; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
  Sao Paulo; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
  Brasilia; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
  Campinas; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
  Goiania; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
  Juiz De Fora; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
  Rio De Janeiro; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
  Sao Paulo; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
  Campinas; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
  Curitiba; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
  Goiania; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
  Porto Alegre; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
  Sao Paulo; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Campinas; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Curitiba; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Goiania; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Rio De Janeiro; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Sao Paulo; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Curitiba; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Goiania; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Porto Alegre; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Rio De Janeiro; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Sao Paulo; Research Site:
  
  
• Rheumatoid Arthritis: A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
  Curitiba; Research Site:
  
  
• Rheumatoid Arthritis: A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
  Goiania; Research Site:
  
  
• Rheumatoid Arthritis: A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
  Sao Paulo; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
  Goiania; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
  Sao Paulo; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Tocilizumab in Patients Completing Treatment in WA17822
  Porto Alegre; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Tocilizumab in Patients Completing Treatment in WA17822
  Sao Paulo; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Campinas; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Goiania; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Rio De Janeiro; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Porto Alegre; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Rio De Janeiro; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Sao Paulo; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Porto Alegre; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Sao Paulo; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Efficacy and Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis
  Campinas; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Efficacy and Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis
  Curitiba; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Efficacy and Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis
  Sao Paulo; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
  Campinas; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
  Curitiba; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
  Sao Paulo; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Campinas; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Goiania; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Rio De Janeiro; Research Site:
  
  
• Rheumatoid Arthritis: SCORE Study: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate.
  Curitiba; Research Site:
  
  
• Rheumatoid Arthritis: SCORE Study: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate.
  Goiania; Research Site:
  
  
• Rheumatoid Arthritis: SCORE Study: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate.
  Porto Alegre; Research Site:
  
  
• Rheumatoid Arthritis: SCORE Study: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate.
  Sao Paulo; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.
  Belo Horizonte; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.
  Brasilia; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.
  Curitiba; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.
  Fortaleza; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.
  Goiania; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.
  Porto Alegre; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.
  Recife; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.
  Ribeirão Preto; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.
  Sao Paulo; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
  Belo Horizonte; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
  Brasilia; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
  Curitiba; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
  Fortaleza; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
  Goiania; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
  Porto Alegre; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
  Recife; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
  Ribeirão Preto; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
  Sao Paulo; Research Site:
  
  

Bulgaria

• Rheumatoid Arthritis: A Study of Tocilizumab in Patients Completing Treatment in WA17822
  Sofia; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Tocilizumab in Patients Completing Treatment in WA17822
  Varna; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Sofia; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Varna; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.
  Pleven; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.
  Sofia; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.
  Teteven; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
  Pleven; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
  Sofia; Research Site:
  
  

Canada

• Bone Density: A four month study with an eight month extension will evaluate the safety and long term usefulness of an osteoporosis medication in post-menopausal female subjects with low bone mineral density (BMD).
  Montreal, QC; Montreal Clinical Study Centre Inc.
  
  
• Lupus: A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.
  Montreal, QC; Research Site:
  
  
• Myasthenia Gravis generalised: A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis
  Edmonton, AB; Research Site:
  
  
• Myasthenia Gravis generalised: A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis
  London, ON; Research Site:
  
  
• Myasthenia Gravis generalised: A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis
  Montreal, QC; Research Site:
  
  
• Post-Menopausal Osteoporosis: DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
  Laval, QC; Research Site:
  
  
• Post-Menopausal Osteoporosis: DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
  Montreal, QC; Research Site:
  
  
• Post-Menopausal Osteoporosis: DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
  Saskatoon, SK; Research Site:
  
  
• Post-Menopausal Osteoporosis: DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
  Toronto, ON; Research Site:
  
  
• Post-Menopausal Osteoporosis: MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
  Calgary, AB; Research Site:
  
  
• Post-Menopausal Osteoporosis: MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
  Quebec City, QC; Research Site:
  
  
• Post-Menopausal Osteoporosis: MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
  Toronto, ON; Research Site:
  
  
• Post-Menopausal Osteoporosis: MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
  Vancouver, BC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
  Burlington, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
  Calgary, AB; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
  Ottawa, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
  Quebec City, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
  Sherbrooke, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
  St John'S; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
  Toronto, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
  Trois-Rivieres, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
  Vancouver, BC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
  Hamilton, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
  Kitchener, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
  Saskatoon, SK; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
  Edmonton, AB; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
  Hamilton, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
  Kelowna, BC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
  Laval, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
  Mississauga, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
  Montreal, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
  Nepean, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
  Ottawa, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
  Quebec City, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
  Sainte-Foy, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
  Sherbrooke, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
  St John'S; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
  St-Eustache, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
  Thunder Bay, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
  Toronto, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
  Trois-Rivieres, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
  Vancouver, BC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
  Victoria, BC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
  Windsor, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
  Winnipeg, MB; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
  Calgary, AB; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
  Hamilton, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
  Ottawa, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
  Winnipeg, MB; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Edmonton, AB; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Hamilton, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Kitchener, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  London, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Mississauga, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Montreal, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Ottawa, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Quebec City, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Toronto, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Trois-Rivieres, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Vancouver, BC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Winnipeg, MB; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Hamilton, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Kitchener, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  London, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Sainte-Foy, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Toronto, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Trois-Rivieres, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Vancouver, BC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Victoria, BC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis.
  Calgary, AB; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis.
  Edmonton, AB; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis.
  London, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis.
  Quebec City, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis.
  Sherbrooke, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis.
  Toronto, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
  Edmonton, AB; Research Site:
  
  
• Rheumatoid Arthritis: A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
  Mississauga, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
  Ottawa, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
  Pointe-Claire, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
  Sainte-Foy, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
  St John'S; Research Site:
  
  
• Rheumatoid Arthritis: A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
  Toronto, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
  Winnipeg, MB; Research Site:
  
  
• Rheumatoid Arthritis: A Study of P38 Inhibitor (4) Monotherapy in Patients With Active Rheumatoid Arthritis
  Edmonton, AB; Research Site:
  
  
• Rheumatoid Arthritis: A Study of P38 Inhibitor (4) Monotherapy in Patients With Active Rheumatoid Arthritis
  Halifax, NS; Research Site:
  
  
• Rheumatoid Arthritis: A Study of P38 Inhibitor (4) Monotherapy in Patients With Active Rheumatoid Arthritis
  Ottawa, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of P38 Inhibitor (4) Monotherapy in Patients With Active Rheumatoid Arthritis
  Toronto, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
  London, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
  Newmarket, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
  Penticton, BC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
  Toronto, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
  Trois-Rivieres, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
  Victoria, BC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
  Winnipeg, MB; Research Site:
  
  
• Rheumatoid Arthritis: A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis.
  Edmonton, AB; Research Site:
  
  
• Rheumatoid Arthritis: A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis.
  Hamilton, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis.
  Mississauga, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis.
  Ottawa, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis.
  Sainte-Foy, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis.
  Sherbrooke, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis.
  St. John's, NL; Research Site:
  
  
• Rheumatoid Arthritis: A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis.
  Vancouver, BC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis.
  Winnipeg, MB; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Tocilizumab in Patients Completing Treatment in WA17822
  Burlington, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Tocilizumab in Patients Completing Treatment in WA17822
  Calgary, AB; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Tocilizumab in Patients Completing Treatment in WA17822
  Montreal, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Tocilizumab in Patients Completing Treatment in WA17822
  Newmarket, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Tocilizumab in Patients Completing Treatment in WA17822
  Ottawa, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Tocilizumab in Patients Completing Treatment in WA17822
  Sainte-Foy, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Tocilizumab in Patients Completing Treatment in WA17822
  St John'S; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Tocilizumab in Patients Completing Treatment in WA17822
  Toronto, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Tocilizumab in Patients Completing Treatment in WA17822
  Victoria, BC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Tocilizumab in Patients Completing Treatment in WA17822
  Winnipeg, MB; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Hamilton, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Ottawa, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Quebec City, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Saskatoon, SK; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Winnipeg, MB; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Burlington, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Calgary, AB; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Montreal, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Newmarket, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Ottawa, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Sainte-Foy, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  St John'S; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Toronto, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Vancouver, BC; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Victoria, BC; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Winnipeg, MB; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
  Burlington, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
  Calgary, AB; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
  Edmonton, AB; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
  Kitchener, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
  London, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
  Mississauga, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
  Montreal, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
  Newmarket, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
  Sainte-Foy, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
  Toronto, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
  Winnipeg, MB; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Efficacy and Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis
  Calgary, AB; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Efficacy and Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis
  London, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Efficacy and Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis
  St John'S; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Efficacy and Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis
  Vancouver, BC; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
  Calgary, AB; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
  St John'S; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
  Vancouver, BC; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Retreatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on anti-TNFalfa Therapy
  Calgary, AB; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Retreatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on anti-TNFalfa Therapy
  Edmonton, AB; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Retreatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on anti-TNFalfa Therapy
  Hamilton, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Retreatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on anti-TNFalfa Therapy
  London, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Retreatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on anti-TNFalfa Therapy
  Toronto, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
  Burlington, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
  Hamilton, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
  Kitchener, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
  Mississauga, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
  Ottawa, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
  Sainte-Foy, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
  St John'S; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
  Victoria, BC; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
  Winnipeg, MB; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNFalfa Therapy
  Calgary, AB; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNFalfa Therapy
  Edmonton, AB; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNFalfa Therapy
  Hamilton, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNFalfa Therapy
  London, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNFalfa Therapy
  Toronto, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNFalfa Therapy
  Vancouver, BC; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Burlington, ON; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Calgary, AB; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Edmonton, AB; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Hamilton, ON; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Kitchener, ON; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  London, ON; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Mississauga, ON; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Montreal, QC; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Ottawa, ON; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Quebec City, QC; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Sainte-Foy, QC; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Saskatoon, SK; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  St John'S; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Toronto, ON; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Victoria, BC; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Winnipeg, MB; Research Site:
  
  
• Rheumatoid Arthritis: SCORE Study: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate.
  Montreal, QC; Research Site:
  
  
• Rheumatoid Arthritis: SCORE Study: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate.
  Ottawa, ON; Research Site:
  
  
• Rheumatoid Arthritis: SCORE Study: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate.
  Quebec City, QC; Research Site:
  
  
• Rheumatoid Arthritis: SCORE Study: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate.
  Saskatoon, SK; Research Site:
  
  
• Rheumatoid Arthritis: SCORE Study: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate.
  St John'S; Research Site:
  
  
• Rheumatoid Arthritis: SCORE Study: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate.
  Toronto, ON; Research Site:
  
  
• Rheumatoid Arthritis: SCORE Study: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate.
  Winnipeg, MB; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.
  Kitchener, ON; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.
  Toronto, ON; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
  London, ON; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
  Montreal, QC; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
  Sherbrooke, QC; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
  Toronto, ON; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
  Vancouver, BC; Research Site:
  
  

Chile

• Post-Menopausal Osteoporosis: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis.
  Santiago; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis.
  Vina Del Mar; Research Site:
  
  
• Rheumatoid Arthritis: A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis.
  Santiago; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.
  Concepcion; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.
  Puente Alto; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.
  Santiago; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
  Concepcion; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
  Puente Alto; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
  Santiago; Research Site:
  
  

China

• Lupus: A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.
  Beijing; Research Site:
  
  
• Lupus: A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.
  Guangdong; Research Site:
  
  
• Lupus: A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.
  Guangzhou; Research Site:
  
  
• Lupus: A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.
  Jiangsu; Research Site:
  
  
• Lupus: